Investigating immune responses in a fruit fly model of frontotemporal dementia

Mechanistic Investigation of Innate Immunity in a Drosophila Model of Frontotemporal Dementia

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10903318

This study is looking at how certain natural defenses in fruit flies might help us understand frontotemporal dementia and ALS better, especially how a specific protein could protect against the damage caused by harmful proteins, which could lead to new treatment ideas for people with these conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10903318 on NIH RePORTER

What this research studies

This research explores the mechanisms of innate immunity in a fruit fly model to understand frontotemporal dementia (FTD) and its connection to amyotrophic lateral sclerosis (ALS). The study focuses on the role of specific antimicrobial peptides, particularly metchnikowin, in mitigating neurodegeneration caused by toxic proteins associated with these diseases. By examining how these peptides interact with neurotoxic elements at a molecular level, the research aims to uncover new pathways that could lead to potential therapeutic targets for FTD and ALS. Patients may benefit from insights gained that could inform future treatments for these conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with frontotemporal dementia or amyotrophic lateral sclerosis, particularly those with genetic links to the C9ORF72 gene.

Not a fit: Patients with other forms of dementia or neurodegenerative diseases not related to FTD or ALS may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating frontotemporal dementia and ALS.

How similar studies have performed: While the specific approach in this research is novel, there have been successful studies investigating immune responses in neurodegenerative diseases, suggesting potential for impactful findings.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAmyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.